J Arnold Wealth Management CO Tyme Technologies, Inc. Transaction History

J Arnold Wealth Management CO

  • $291 Million
  • Q4 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Sep 08, 2021
SELL
$0.9 - $1.95 $16,042 - $34,758
-17,825 Closed
0 $0
Q4 2019

Sep 08, 2021
BUY
$1.0 - $1.49 $17,825 - $26,559
17,825 New
17,825 $25,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track J Arnold Wealth Management CO Portfolio

Follow J Arnold Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J Arnold Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on J Arnold Wealth Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email